FindTrial
Sign In

Evaluating how effective Quad Shot treatment is for advanced Head and Neck Cancer patients

Response Assessment In Incurable / Recurrent / Metastatic Cancers Of Various Sites Using Quad Shot Regimen Of Palliative Radiation Therapy - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067194
Enrollment
50
Registered
2024-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Quad Shot: 3.7 Gy BD dose for 2 days followed by 28 days gap. Total 3 cycles. Control Intervention1: Nil: Nil

Sponsors

Pt JNM Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Incurable/Recurrent/Metastatic Cancer Not Amenable For Any Curative Treatment ECOG Grade Less Than Or Equal To 3

Exclusion criteria

Exclusion criteria: Prior Radiation To Same Site

Design outcomes

Secondary

MeasureTime frame
To Assess The Acute Toxicities Developed In The Patients During The Course Of TreatmentTimepoint: 4 Weekly For 12 Weeks Of Therapy—

Primary

MeasureTime frame
To Assess The Response In Patients Treated With Quad Shot Course Using Objective Response By Clinical And Radiological Imaging Subjective Response By ESAS Scale Timepoint: 4 weekly—

Countries

India

Contacts

Public ContactDr Rahul Swaroop Singh

Pt. JNM Medical College Raipur

rahul_singh2755@yahoo.com9479884343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026